Heritage Family Offices’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.29M Buy
1,911
+454
+31% +$464K 0.89% 27
2026
Q1
$1.34M Buy
1,457
+199
+16% +$202K 0.59% 40
2025
Q4
$1.35M Sell
1,258
-59
-4% -$56.4K 0.61% 38
2025
Q3
$1M Sell
1,317
-821
-38% -$611K 0.47% 50
2025
Q2
$1.76M Hold
2,138
0.89% 28
2025
Q1
$1.77M Buy
2,138
+174
+9% +$145K 0.9% 28
2024
Q4
$1.52M Buy
1,964
+37
+2% +$30.6K 0.76% 30
2024
Q3
$1.71M Sell
1,927
-15
-0.8% -$13.5K 0.88% 26
2024
Q2
$1.76M Buy
+1,942
New +$1.55M 0.98% 22

Other funds holding LLY

Heritage Family Offices's LLY Position: Q2 2026 in Review

Heritage Family Offices increased its Eli Lilly (LLY) stake by 31% in Q2 2026, buying an estimated $464K and bringing the position to 1,911 shares worth $2.29M. The position accounts for 0.89% of the portfolio, ranked #27.

Heritage Family Offices first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Heritage Family Offices held 1,911 shares of Eli Lilly worth $2.29M as of Q2 2026.
  • Heritage Family Offices bought 454 Eli Lilly shares in Q2 2026, an estimated $464K.
  • Eli Lilly made up 0.89% of Heritage Family Offices's portfolio in Q2 2026, its #27 holding.
  • Heritage Family Offices first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Heritage Family Offices's 13F filing for Q2 2026, filed 29 Jul 2026.